Drug Information Services in Nepal: An Overview, Present Scenario and Future Perspective
Keywords:
drug information, drug information center/service, pharmacy practice, pharmacistAbstract
Introduction
Drug Information Centre (DIC) provides services regarding several aspects of drug information, to healthcare professionals and consumers, that are impartial, updated, well-referenced, and critically evaluated.1 This information required ranges from therapeutic information for the treatment of patient, comparision of efficacy, potency and costs, market availability to even recent advances in drugs.2 Drug information is a speciality area within the realm of clinical and hospital pharmacy services and drug information specialists have clinical knowledge and skills that allow them to provide clear, concise, and accurate recommendations regarding drug use.3 Pharmacists or clinical pharmacists or other trained health workers provide drug information service or medicine information services to enhance rational prescribing, improve medication safety by reducing medication error and increase medication adherence.1
Need for Drug Information
In developing countries like Nepal, where most of the general population belongs to the low-income category, with multiple health care systems and a lack of reliable information about the risks and benefits of drug therapy, a system for authentic, unbiased and evidence-based drug information could explicitly contribute to information needs of the people.1 In the past, there were limited number of available drugs, but now, newer drugs and multiple treatment combinations are being introduced for effective and efficient treatment and control of various diseases. Doctors get information, especially about newer drugs from medical representatives who are generally biased towards their product.4 Hence lack of accurate drug information service poses a problem and affects the pharmacotherapeutic process. Furthermore, over 20,000 biomedical journals are available worldwide and more than 6,000 journals are published every day.4 This means literature review itself becomes time-consuming for doctors to keep themselves well informed with the latest drug information. Hence it is challenging for health care professionals to keep themselves up-to-date by extracting unbiased information with available resources. On the other hand, patients often are interested to know about drug availability, its side effects and drug interactions if under multiple medications.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Trilochan Panday, Pawan Maharjan, Subodh Dhakal, Prity Dongol, Sharmila Shrestha, Priya Chaudhary, Puja Lama, Ganesh Dangal
This work is licensed under a Creative Commons Attribution 4.0 International License.
The author(s) retain the copyright and the full publishing right without restriction under the Creative Commons Attribution 4.0 International License (CC BY 4.0) which allows readers to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) for any purpose, even commercially, provided the work is properly attributed. (https://creativecommons.org/licenses/by/4.0/).
Author(s) grant the non-exclusive publishing right to the Journal of Karnali Academy of Health Sciences (JKAHS). The publishing rights include the rights to publish, reproduce, distribute, include in indexes or search databases or other media in print or online. The JKAHS may require revisions to the manuscript before acceptance for publication or may choose not to publish it based on the judgement of the editors. Further, JKAHS might retract, withdraw, or publish a correction or other notice after publication, if such publication would be inconsistent with the good publication practices and associated guidelines set forth by the COPE (Committee on Publication Ethics) (https://publicationethics.org/core-practices).
More information about the Creative Commons Attribution 4.0 International License can be found in the webpage of Creative Commons (CC) by following the link provided below: https://creativecommons.org/licenses/by/4.0/